Kronik Pankreatit Tanı ve Tedavi Yaklaşımları

Yazarlar

Sercan Büyükakıncak

Özet

Kronik pankreatit, pankreasta fibrozis ve inflamasyona bağlı olarak endokrin ve ekzokrin fonksiyon bozukluklarıyla seyreden kronik ve ilerleyici bir hastalıktır. En sık 35-55 yaş aralığındaki erkeklerde gözlenen bu tablonun temel etiyolojik faktörü, vakaların %70-80’inden sorumlu olan aşırı alkol kullanımıdır. Hastalığın en yaygın klinik semptomu epigastriumda başlayıp sırta yayılan şiddetli karın ağrısıdır; buna zamanla zayıflama, steatore ve diabetes mellitus eşlik eder. Tanı aşamasında kontrastlı batın tomografisi ilk tercih edilen yöntemlerden biri olup, erken evrelerde ve kanal yapılarının incelenmesinde MRCP, EUS ve sekretin stimülasyon testi gibi spesifik fonksiyon testlerinden yararlanılır. Kronik süreçte hastalarda psödokist oluşumu, safra kanalı tıkanıklığı ve duktal adenokarsinom gibi malignite gelişme riski önemli ölçüde artmaktadır. Tedavi yaklaşımı öncelikle diyet düzenlemeleri, pankreatik enzim replasmanı ve ağrı kontrolünü içeren semptomatik medikal destekten oluşur. Ancak, medikal tedaviye yanıt vermeyen şiddetli ağrı, narkotik bağımlılığı, organ obstrüksiyonları veya kanser şüphesi varlığında Whipple, Beger veya Puestow gibi rezektif veya dekompresyon amaçlı cerrahi yöntemlere başvurulur.

Chronic pancreatitis is a progressive inflammatory disease characterized by irreversible fibrosis and the impairment of endocrine and exocrine pancreatic functions. Most commonly observed in men aged 35-55, the primary etiological factor is chronic alcohol abuse, which accounts for 70-80% of all cases. The most prevalent clinical manifestation is severe epigastric abdominal pain radiating to the back, which is frequently accompanied by significant weight loss, steatorrhea, and diabetes mellitus over time. Diagnosis primarily relies on contrast-enhanced abdominal computed tomography (CT), while MRCP, EUS, and specific pancreatic function tests like the secretin stimulation test are utilized in early stages and for detailed ductal evaluation. The chronic course significantly elevates the risk of severe complications, including pseudocyst formation, biliary obstruction, and pancreatic ductal adenocarcinoma. Management mainly comprises symptomatic medical support, including dietary modifications, pancreatic enzyme replacement therapy, and pain control. However, in cases of intractable pain, narcotic dependency, complications, or suspicion of malignancy, surgical interventions—classified as resective procedures like Whipple and Beger or decompressive procedures like Puestow—are required to improve quality of life.

Referanslar

Cawley T, A singular case of diabetes, consisting entirely in the quantity of urine: with an inquirey into the different theories of the disease. London Medical Journal, 1788; 9: pp. 286-308.

Yadav D, Timmons L, Benson J.T, et al. Incidence, prevalence, and survival of chronic pancreatitis: a population-based study. Am J Gastroenterol 2011; 106: pp. 2192-2199.

Conwell DL, Lee LS, Yadav D, et al. American Pancreatic Association practice guidelines in chronic pancreatitis. Pancreas. 2014;43(8):1143–1162.

Yeo CJ, Cameron JL, Lillemoe KD, et al. Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients. Ann Surg 1995; 221: 721-33.

Etemad B, Whitcomb DC. Chronic pancreatitis: Diagnosis, classifi-cation, and new genetic developments. Gastroenterology 2001; 120:682-707.

Forsmark C.E. Chronic pancreatitis.Elsevier SaundersPhiladelphia:2016. 994-1026.

Karaahmet F. , Kekilli M. Kronik pankreatit’te endoskopik tedavi: tek merkez sonuçları. Ortadoğu Tıp Dergisi. 2018; 10(3): 343-347.

Kamisawa T, Funata N, Hayashi Y, et. al. A new clinicopathological entity of IgG4-related autoimmune disease. J Gastroenterol 2003; 38: pp. 982-984.

Warshaw A.L, Simeone J.F, Schapiro R.H, et. al. Evaluation and treatment of the dominant dorsal duct syndrome (pancreas divisum redefined). Am J Surg 1990; 159: pp. 59-64.

Hart P.A, Zen Y, Chari S.T. Recent advances in autoimmune pancreatitis. Gastroenterology 2015; 149: pp. 39-51.

Zamboni G, Luttges J, Capelli P, et. al. Histopathological features of diagnostic and clinical relevance in autoimmune pancreatitis: a study on 53 resection specimens and 9 biopsy specimens. Virchows Arch 2004; 445: pp. 552-563.

Michelle Stram MD ,Shu Liu PhD,Aatur D. Surgical Pathology Clinics, 2016-12-01, Volume 9, Issue 4, Pages 643-659

Conwell DL, Banks PA, Sandhu BS, et al. Validation of demographics, etiology, and risk factors for chronic pancreatitis in the USA: a report of the North American Pancreas Study (NAPS) Group. Dig Dis Sci. 2017;62(8):2133–2140.

Varghese JC, Farrell MA, Courtney G, et al. A prospective comparison of magnetic resonance cholangiopancreatography with endoscopic retrograde cholangiopancreatography in the evaluation of patients with suspected biliary tract disease. Clin Radiol 1999; 54:513–520.

Muniraj T, Aslanian HR, Farrell J, et al. Chronic pancreatitis, a comprehensive review and update. Part I: epidemiology, etiology, risk factors, genetics, pathophysiology, and clinical features. Dis Mon. 2014;60(12):530–550.

Ahmed SA, Wray C, Rilo HL, et al. Chronic pancreatitis: recent advances and ongoing challenges. Curr Probl Surg. 2006;43(3):127–238.

Chen WX, Zhang WF, Li B, et al. Clinical manifestations of patients with chronic pancreatitis. Hepatobiliary Pancreat Dis Int. 2006;5(1):133–137.

Beyler AR, Dökmeci A, Erten A, ve ark. Kronik pankreatit etyoloji-sinde rol oynayan faktörler. Gastroenteroloji 1993; 4: 319-2.

Barry K.Am Fam Physician. 2018 Mar 15;97(6):385-393.

Kloppel G, Adsay N.V. Chronic pancreatitis and the differential diagnosis versus pancreatic cancer. Arch Pathol Lab Med 2009; 133: pp. 382-387.

Ş Gök ve ark. Kronik pankreatit tanısında fekal elastaz klinik önemi.Yeni Tıp Dergisi 2008;25: 213-216.

Remer EM, Baker ME. Imaging of chronic panc-reatitis. Radiol Clin North Am 2002; 40: 1229-42.

Bolondi L,Li Bassi S,Gaiani S,Barbara L Radiologic Clinics of North America, 01 Jul 1989, 27(4):815-833.

Stevens T, Lopez R, Adler DG, et al. Multicenter compari-son of the interobserver agreement of standard EUS scoring and Rosemont classification scoring for di-agnosis of chronic pancreatitis. Gastrointest Endosc 2010; 71: 519-26.

Fernando I. Yamauchi , Cinthia D, et al. Multidetector CT Evaluation of the Postoperative Pancreas Radio Graphics Vol. 2012.32-3.

Yayınlanan

2 Şubat 2022

Lisans

Lisans